Variation in make-up of generic epilepsy drugs can lead to dosing problems

Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study suggests.

Genes Biology Biotechnology Children\\\'s Health